The Centers for Medicare & Medicaid Services late this afternoon released a proposed rule that would make programmatic and operational changes to the Medicare Advantage and prescription drug benefit programs for contract year 2019. According to the agency, the rule would revise program regulations to implement certain provisions of the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act, among other changes. AHA staff are reviewing the rule. Watch for more information. 

Related News Articles

Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
A JAMA study published Aug. 18 found that plan design changes by Medicare Part D insurers, particularly for Medicare Advantage plans, following passage of the…
Headline
The Centers for Medicare & Medicaid Services today announced a nationwide initiative aimed at reinforcing eligibility standards for Medicaid and the…
Headline
The Centers for Medicare & Medicaid Services has issued the 2025-2026 Medicaid Managed Care Rate Development Guide for states to use when setting managed…
Headline
The AHA on Aug. 14 at 1 p.m. ET will host a webinar on age-friendly health systems and how they can strengthen care delivery. Adam Koontz, senior director of…
Headline
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory…